About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
How to Identify and Manage Ph-like ALL
By
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
FEATURING
Sarah K. Tasian
By
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
FEATURING
Sarah K. Tasian
0 views
November 29, 2018
Comments
0
Login to view comments.
Click here to Login
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Recommended
AUTOPLAY
ON
Related
Newest
08:18
Insights from 2023 ASH Annual Meeting
Treatment Strategies for Hematocrit Control in PV
Feat.
A. Zhou
06:00
2024 Clinical Case Studies
Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration
Feat.
A. Geisler
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
06:51
Insights from 2023 ASH Annual Meeting
Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…
Feat.
D. Tremblay
10:49
Monia Marchetti
Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
37:12
Tisch Cancer Institute at Mount Sinai
Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: 6…
Feat.
M. Metzger
13:29
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in ALL
Feat.
B. Shah
25:01
Indy Hematology Review
Review of Emerging Therapies and Top Trials in Hematologic Malignanc…
Feat.
R. Birhiray
20:32
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Malignancy Associated Hemophagocytic Lymphohistiocytosis: Diagnosis …
Feat.
S. Kalayoglu Besisik
08:04
2nd SOHO Italian Conference
Cell Morphology in Acute Leukemias & Hematologic Malignancies: D…
Feat.
G. Zini
13:54
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on Asparaginase-Related Toxicity in AYAs With ALL: …
Feat.
K. Schmiegelow
23:01
Indy Hematology Review
Improvements in Treating Ph-like ALL, Trials in Pre B-ALL & Blin…
Feat.
H. Kantarjian
22:50
UNMC Leukemia Symposium: Focus on Opportunities to Improve Care
Palliative vs. Hospice Care & Benefits of Early Integration of P…
Feat.
M. Teply
03:47
Indy Hematology Review
Challenging Cases in Leukemia: AML & ALL
Feat.
M. Wiemann
08:18
Penn Medicine Abramson Cancer Center
The Making of the Tisagenlecleucel CAR T
Feat.
C. June
43:39
Leonard Calabrese
T-cell Activation, Deactivation and Control and the Impact of Cancer…
23:27
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
Stem Cell Transplant for Ph+ ALL: Who, When, How
Feat.
F. Lussana
